T cells were found to be localizing selectively around a distinct malignant duct located center-left of the tissue section, with attributed genes such as immune checkpoint costimulatory receptor CD28, as well as IFIT3, CCL5, and PLAAT4 implicating an active anti-tumor immune response. The gene discussed is CD28; the disease is neoplasm.